Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1477910 | 1.00 | CYP2C19 (0.42) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| Hydrochloric Acid SCHEMBL11825341 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6913628 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6914795 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6917016 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6909889 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6917012 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6914957 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| Hydrochloric Acid SCHEMBL11815475 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 | |
| SCHEMBL6915754 | 0.97 | CYP2C19 (0.41) | CYP2C19FFAR3SMN1; SMN2ALDH1A1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111072656-B | Praziquantel synthesis method | 江苏诚信药业有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-114957156-A | Compound containing benzoxazine structure, resin composition, prepreg and electric copper clad laminate, and preparation method and application thereof | 成都科宜高分子科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-216778836-U | Synthetic cauldron of cyclohexanecarbonyl chloride | 山东嘉瑞化工有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-110818767-B | Preparation and purification method of 3-O-cyclohexanecarboxyl-11-carbonyl-beta-boswellic acid or analogue thereof | 江苏博创园生物医药科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-214567833-U | Cyclohexanecarboxylic acid chloride receiving device | 阜新金丰氟化工有限公司 | 2021-11-02 | — | — | CN | claimed |
| CN-212166567-U | Rectifying tower for cyclohexanecarbonyl chloride reaction | 阜新金丰氟化工有限公司 | 2020-12-18 | — | — | CN | claimed |
| CN-210752699-U | Synthetic cauldron of cyclohexanecarbonyl chloride | 阜新金丰氟化工有限公司 | 2020-06-16 | — | — | CN | claimed |
| CN-111072656-A | Synthetic method of praziquantel | 江苏诚信药业有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-107001359-B | process for preparing praziquantel and precursors thereof | 默克专利股份有限公司 | 2019-12-17 | — | — | CN | claimed |
| EP-3075739-B1 | A PENTACYCLIC TRITERPENOID COMPOUND WITH MODIFIED STRUCTURE AND PREPARATION METHOD AND USE THEREOF | SUZHOU BOTANY BIOMEDICALS CO LTD (CN) | 2018-10-17 | — | — | EP | claimed |
| US-20170002039-A1 | A Pentacyclic Triterpenoid Compound with Modified Structure and Preparation Method and Use Thereof | SUZHOU BOTANY BIOMEDICALS CO., LTD. (CN) | 2017-01-05 | — | — | US | claimed |
| EP-3075739-A1 | A PENTACYCLIC TRITERPENOID COMPOUND WITH MODIFIED STRUCTURE AND PREPARATION METHOD AND USE THEREOF | Suzhou Botany Biomedicals Co., Ltd (CN) | 2016-10-05 | — | — | EP | claimed |
| WO-2016078765-A1 | METHOD FOR THE PRODUCTION OF PRAZIQUANTEL AND PRECURSORS THEREOF | MERCK PATENT GMBH (DE) | 2016-05-26 | — | — | WO | claimed |
| EP-1521828-A2 | PRODUCTION OF POLYKETIDES | Biotica Technology Limited (GB) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007709-A2 | PRODUCTION OF POLYKETIDES | BIOTICA TECHNOLOGY LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| US-4772678-A | HIGH-MOLECULAR-WEIGHT CHAIN-EXTENDED N-HETEROCYCLIC POLYMERS PREPARED USING A NON-OXIDIZING STRONG ACID AS SOLVENT; HIGH-STRENGTH FIBERS, FILMS, FIBRIDS AND STRUCTURES | COMMTECH INTERNATIONAL MANAGEMENT CORPORATION (US) | 1988-09-20 | — | — | US | claimed |
| US-4703103-A | POLYPHOSPHORIC ACID CATALYST | COMMTECH INTERNATIONAL (US) | 1987-10-27 | — | — | US | claimed |
| WO-1985004178-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | SRI INTERNATIONAL (US) | 1985-09-26 | — | — | WO | claimed |
| US-4211727-A | CADMIUM BOROHYDRIDE COMPLEX AS REDUCING AGENT | SHELL OIL COMPANY (US) | 1980-07-08 | — | — | US | claimed |
| US-4197374-A | FOAMS, FILMS, FIBERS, COATINGS, ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1980-04-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170002039-A1 | A Pentacyclic Triterpenoid Compound with Modified Structure and Preparation Method and Use Thereof | IL17A, NFATC1, RORC | CYP2C19 694/4885FFAR3 612/4885SMN1; SMN2 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.